Keywords: crucell, signs, per, c6, deal, vascular, biogenics

Crucell signs PER.C6 deal with Vascular Biogenics

Article | 11 April 2005

Print This

Dutch biotechnology group Crucell has entered into a licensing agreement with Israeli firm Vascular Biogenics for use of the former's ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in